Evidence map›Paper›PMID 38399282›Full record

ArticlePharmaceutics2024

Nanogallium-poly(L-lactide) Composites with Contact Antibacterial Action.

Mario Kurtjak, Marjeta Maček Kržmanc, Matjaž Spreitzer, Marija Vukomanović

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mario KurtjakJožef Stefan Institute (JSI), Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0002-2334-5920
Marjeta Maček KržmancJožef Stefan Institute (JSI), Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3436-5692
Matjaž SpreitzerJožef Stefan Institute (JSI), Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4704-7020
Marija VukomanovićJožef Stefan Institute (JSI), Jamova cesta 39, 1000 Ljubljana, Slovenia.ORCID 0000-0001-7034-0471
Jožef Stefan Institute · SI

Funding

Slovenian Research Agency J3-14531Slovenian Research Agency P2-0091
6 · The paper itself

Abstract

In diverse biomedical and other applications of polylactide (PLA), its bacterial contamination and colonization are unwanted. For this reason, this biodegradable polymer is often combined with antibacterial agents or fillers. Here, we present a new solution of this kind. Through the process of simple solvent casting, we developed homogeneous composite films from 28 ± 5 nm oleic-acid-capped gallium nanoparticles (Ga NPs) and poly(L-lactide) and characterized their detailed morphology, crystallinity, aqueous wettability, optical and thermal properties. The addition of Ga NPs decreased the ultraviolet transparency of the films, increased their hydrophobicity, and enhanced the PLA structural ordering during solvent casting. Albeit, above the glass transition, there is an interplay of heterogeneous nucleation and retarded chain mobility through interfacial interactions. The gallium content varied from 0.08 to 2.4 weight %, and films with at least 0.8% Ga inhibited the growth of

Indexed as

antibacterial compositecontact-based antimicrobialgallium nanoparticleshuman keratinocytespolylactide filmPseudomonas aeruginosa

Identifiers

PMID38399282
PMCPMC10893416
OpenAlexW4391540425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.